Development and evaluation of an automated hepatitis C virus NS5B sequence-based subtyping assay

Clinical Chemistry and Laboratory Medicine

Volumn 48, Issue 8, 2010, Pages 1095-1102

  Koletzki, Diana ^a   Dumont, Stéphanie ^a   Vermeiren, Hans ^a,b   Fevery, Bart ^a   De Smet, Pieter ^a,c   Stuyver, Lieven J ^a  

^a Virco BVBA   (Belgium)

^b GALAPAGOS NV   (Belgium)

^c MIPS NV   (Belgium)

Author keywords

hepatitis C virus; NS5B; sequencing; subtype

Indexed keywords

NONSTRUCTURAL PROTEIN 5B; VIRUS RNA;

ACCURACY; AMINO ACID SEQUENCE; ARTICLE; FLUORESCENCE RESONANCE ENERGY TRANSFER; GENE AMPLIFICATION; GENOTYPE; HEPATITIS C VIRUS; NONHUMAN; NUCLEOTIDE SEQUENCE; PHYLOGENETIC TREE; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; VIRUS GENE; VIRUS LOAD;

AUTOMATION; GENOTYPE; HEPACIVIRUS; HUMANS; PHYLOGENY; PROTEIN SUBUNITS; REAGENT KITS, DIAGNOSTIC; RNA, VIRAL; SEQUENCE ANALYSIS, RNA; VIRAL LOAD; VIRAL NONSTRUCTURAL PROTEINS;

HEPATITIS C VIRUS;

EID: 77955439878     PISSN: 14346621     EISSN: 14374331     Source Type: Journal    
DOI: 10.1515/CCLM.2010.236     Document Type: Article

References (41)

1. Choo QL, Kuo G, Weiner AJ, Overby LR, Bradley DW, Houghton M. Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science 1989;244:359-362
2. Simmonds P, Bukh J, Combet C, Deleage G, Enomoto N, Feinstone S, et. al. Consensus proposals for a unified system of nomenclature of hepatitis C virus genotypes. Hepatology 2005;42:962-973
3. Kuiken C, Simmonds P. Nomenclature and numbering of the hepatitis C virus. Method Mol Biol 2009;510:33-53.
4. Hadziyannis SJ, Koskinas JS. Differences in epidemiology, liver disease and treatment response among HCV genotypes. Hepatol Res 2004;29:129-135
5. Manns MP, McHutchison JG, Gordon SC, Rustgi VK, Shiffman M, Reindollar R, et. al. Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial. Lancet 2001;358: 958-965
6. Pawlotsky JM. Mechanisms of antiviral treatment efficacy and failure in chronic hepatitis C. Antiviral Res 2003;59:1-11.
7. Sarrazin C, Kieffer TL, Bartels D, Hanzelka B, Muh U, Welker M, et. al. Dynamic hepatitis C virus genotypic and phenotypic changes in patients treated with the protease inhibitor telaprevir. Gastroenterology 2007;132:1767-1777
8. Simmonds P, Holmes EC, Cha TA, Chan SW, McOmish F, Irvine B, et. al. Classification of hepatitis C virus into six major genotypes and a series of subtypes by phylogenetic analysis of the NS-5 region. J Gen Virol 1993;74(Pt 11):2391-2399
9. Stuyver L, van Arnhem W, Wyseur A, Hernandez F, Delaporte E, Maertens G. Classification of hepatitis C viruses based on phylogenetic analysis of the envelope 1 and nonstructural 5B regions and identification of five additional subtypes. Proc Natl Acad Sci USA 1994;91:10134-10138
10. Stuyver L, Wyseur A, van Arnhem W, Hernandez F, Maertens G. Second-generation line probe assay for hepatitis C virus genotyping. J Clin Microbiol 1996;34:2259-2266
11. Okamoto H, Sugiyama Y, Okada S, Kurai K, Akahane Y, Sugai Y, et. al. Typing hepatitis C virus by polymerase chain reaction with type-specific primers: application to clinical surveys and tracing infectious sources. J Gen Virol 1992;73:673-679
12. Nakao T, Enomoto N, Takada N, Takada A, Date T. Typing of hepatitis C virus genomes by restriction fragment length polymorphism. J Gen Virol 1991;72:2105-2112
13. White PA, Zhai X, Carter I, Zhao Y, Rawlinson WD. Simplified hepatitis C virus genotyping by heteroduplex mobility analysis. J Clin Microbiol 2000;38:477-482
14. Hu YW, Balaskas E, Furione M, Yen PH, Kessler G, Scalia V, et. al. Comparison and application of a novel genotyping method, semiautomated primer-specific and mispair extension analysis, and four other genotyping assays for detection of hepatitis C virus mixed-genotype infections. J Clin Microbiol 2000;38: 2807-2813
15. Schroter M, Zollner B, Schafer P, Landt O, Lass U, Laufs R, et. al. Genotyping of hepatitis C virus types 1, 2, 3, and 4 by a one-step LightCycler method using three different pairs of hybridization probes. J Clin Microbiol 2002;40:2046-2050
16. Dixit V, Quan S, Martin P, Larson D, Brezina M, DiNello R, et. al. Evaluation of a novel serotyping system for hepatitis C virus: strong correlation with standard genotyping methodologies. J Clin Microbiol 1995;33:2978-2983
17. Germer JJ, Majewski DW, Yung B, Mitchell PS, Yao JD. Evaluation of the invader assay for genotyping hepatitis C virus. J Clin Microbiol 2006;44:318-323
18. Ledford M, Friedman KD, Hessner MJ, Moehlenkamp C, Williams TM, Larson RS. A multi-site study for detection of the factor V (Leiden) mutation from genomic DNA using a homogeneous invader microtiter plate fluorescence resonance energy transfer (FRET) assay. J Mol Diagn 2000;2:97-104.
19. Stuyver L, Wyseur A, van Arnhem W, Lunel F, Laurent-Puig P, Pawlotsky JM, et. al. Hepatitis C virus genotyping by means of 59-UR/core line probe assays and molecular analysis of untypeable samples. Virus Res 1995;38:137-157
20. Maertens G, Stuyver L. Genotypes and genetic variation of hepatitis C virus. In: Harrison TJ, Zuckerman AJ, editors. The molecular medicine of viral hepatitis. Chichester, England: Wiley, 1997:182-233.
21. Sandres-Saune K, Deny P, Pasquier C, Thibaut V, Duverlie G, Izopet J. Determining hepatitis C genotype by analyzing the sequence of the NS5b region. J Virol Method 2003;109:187-193
22. Simmonds P, Smith DB, McOmish F, Yap PL, Kolberg J, Urdea MS, et. al. Identification of genotypes of hepatitis C virus by sequence comparisons in the core, E1 and NS-5 regions. J Gen Virol 1994;75(Pt 5):1053-1061
23. Stelzl E, van der Meer C, Gouw R, Beld M, Grahovac M, Marth E, et. al. Determination of the hepatitis C virus subtype: comparison of sequencing and reverse hybridization assays. Clin Chem Lab Med 2007;45:167-170
24. Thompson JD, Higgins DG, Gibson TJ. CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acid Res 1994;22:4673-4680
25. Altschul SF, Madden TL, Schaffer AA, Zhang J, Zhang Z, Miller W, et. al. Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucleic Acid Res 1997; 25:3389-3402
26. Tamura K, Dudley J, Nei M, Kumar S. MEGA4: Molecular Evolutionary Genetics Analysis (MEGA) software version 4.0. Mol Biol Evol 2007;24:1596-1599
27. Davis GL, Esteban-Mur R, Rustgi V, Hoefs J, Gordon SC, Trepo C, et. al. Interferon alfa-2b alone or in combination with ribavirin for the treatment of relapse of chronic hepatitis C. International Hepatitis Interventional Therapy Group. N Engl J Med 1998;339:1493-1499
28. Izopet J, Payen JL, Alric L, Sandres K, Charlet JP, Vinel JP, et. al. Baseline level and early suppression of serum HCV RNA for predicting sustained complete response to alpha-interferon therapy. J Med Virol 1998;54:86-91.
29. McHutchison JG, Gordon SC, Schiff ER, Shiffman ML, Lee WM, Rustgi VK, et. al. Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy Group. N Engl J Med 1998; 339:1485-1492
30. Poynard T, McHutchison J, Goodman Z, Ling MH, Albrecht J. Is an "a la carte'' combination interferon alfa-2b plus ribavirin regimen possible for the first line treatment in patients with chronic hepatitis C? The ALGOVIRC Project Group. Hepatology 2000;31:211-218
31. Simmonds P. Genetic diversity and evolution of hepatitis C virus - 15 years on. J Gen Virol 2004;85:3173-3188
32. Enomoto N, Takada A, Nakao T, Date T. There are two major types of hepatitis C virus in Japan. Biochem Biophys Res Commun 1990;170:1021-1025
33. Nolte FS, Green AM, Fiebelkorn KR, Caliendo AM, Sturchio C, Grunwald A, et. al. Clinical evaluation of two methods for genotyping hepatitis C virus based on analysis of the 59 noncoding region. J Clin Microbiol 2003;41:1558-1564
34. Koletzki D, Dumont S, Fevery B, De Smet P, Vermeiren H, Stuyver LJ. Development of an integrated platform to detect drug resistance mutations in the non-structural protein region of the hepatitis C virus genotypes 1, 2, 3, and 4. Rev Antivir Ther 2008;5:23.
35. Krajden M, Ziermann R, Khan A, Mak A, Leung K, Hendricks D, et. al. Qualitative detection of hepatitis C virus RNA: comparison of analytical sensitivity, clinical performance, and workflow of the Cobas Amplicor HCV test version 2.0 and the HCV RNA transcription-mediated amplification qualitative assay. J Clin Microbiol 2002;40:2903-2907
36. Chen Z, Weck KE. Hepatitis C virus genotyping: interrogation of the 59 untranslated region cannot accurately distinguish genotypes 1a and 1b. J Clin Microbiol 2002;40:3127-3134
37. Laperche S, Lunel F, Izopet J, Alain S, Deny P, Duverlie G, et. al. Comparison of hepatitis C virus NS5b and 59 noncoding gene sequencing methods in a multicenter study. J Clin Microbiol 2005;43:733-739
38. Lau JY, Mizokami M, Kolberg JA, Davis GL, Prescott LE, Ohno T, et. al. Application of six hepatitis C virus genotyping systems to sera from chronic hepatitis C patients in the United States. J Infect Dis 1995;171:281-289
39. Martro E, Gonzalez V, Buckton AJ, Saludes V, Fernandez G, Matas L, et. al. Evaluation of a new assay in comparison with reverse hybridization and sequencing methods for hepatitis C virus genotyping targeting both 59 noncoding and nonstructural 5b genomic regions. J Clin Microbiol 2008;46:192-197
40. Verbeeck J, Stanley MJ, Shieh J, Celis L, Huyck E, Wollants E, et. al. Evaluation of versant hepatitis C virus genotype assay (LiPA) 2.0. J Clin Microbiol 2008;46:1901-1906.
41. Hraber PT, Fischer W, Bruno WJ, Leitner T, Kuiken C. Comparative analysis of hepatitis C virus phylogenies from coding and non-coding regions: The 59 untranslated region (UTR) fails to classify subtypes. Virol J 2006;3:103.